Phytopharm Interim Results PharmaLive.com (press release), PA - Kevin Povey, R&D Programme Director, Unilever, commented: “We are satisfied with the good progress to date with Hoodia and anticipate submitting our GRAS ... |
Thursday, May 29, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment